AzTrials
AzTrials

Multiple SclerosisNCT04973501

Functional Disorders of the Musculoskeletal System in People With Multiple Sclerosis

A study testing Manual physiotherapeutic correction (MFK) Method and Dynamic Neuromuscular Stabilization (DNS) Method in people with Multiple Sclerosis and Rehabilitation, run by Charles University, Czech Republic.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The randomized controlled trial is aimed to study the efficacy of treatment approaches based on developmental kinesiology models and its impact on balance, gait and mobility in people with mild to severe multiple sclerosis (pwMS). Read more about this study

Who is it for?
Ages 18 to 70 years
What is being tested?
Manual physiotherapeutic correction (MFK) Method and Dynamic Neuromuscular Stabilization (DNS) Method
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
No sites listed yet
Study dates
May 2016to Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • exact diagnosis of MS stated by neurologist
  • Expanded Disability Status Scale (EDSS) ≥ 2 and ≤ 6,5
  • no previous physiotherapy in six months
  • no clinical relapses and changes in pharmacotherapy in the previous month or during the rehabilitation trial
  • ability to undergo ambulatory physiotherapy

Who cannot join

  • other neurological disease or conditions disabling movement (e.g. stroke, pregnancy, fracture)

About this study

Official title: Evaluation of the Effect of the Physiotherapy on Mobility and Functional Disorders of the Musculoskeletal System in People With Multiple Sclerosis

The randomized controlled trial is aimed to study the efficacy of treatment approaches based on developmental kinesiology models and its impact on balance, gait and mobility in people with mild to severe multiple sclerosis (pwMS). The main goal is to compare two out-patient physiotherapeutic methods, that will be attended 1-hour twice a week for one month and once a week for next two months (16 therapies in total). The efficacy will be assessed by a blinded independent clinical examiner using clinical examination and questionnaire survey one month before the therapy programme, immediately before and after the therapy and two months after termination of the therapy.

Read the detailed description

The participants were randomly divided into two groups for three-month outpatient physiotherapeutic programme.

One group obtained treatment by MFK Method (Manual physiotherapeutic correction) and the second by DNS (Dynamic Neuromuscular Stabilization ). Both treatment methods were developed in the Czech Republic. All participants attended 1-hour MFK Method or DNS twice a week for one month and once a week for next two months (16 therapies in total).

The participants were examined three times - before the start of the physiotherapy program, immediately after its completion and six months apart.

Being tested
Manual physiotherapeutic correction (MFK) Method, Dynamic Neuromuscular Stabilization (DNS) Method
Keywords
Developmental kinesiology, Physiotherapy, Muscle imbalance, Musculoskeletal disorders
Medical subject headings
Multiple Sclerosis, Musculoskeletal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Manual physiotherapeutic correction (MFK) MethodBehavioural

    Patients undergo ambulatory physiotherapy :1-hour duration, twice a week for one month and once a week for next two months (16 therapies in total). Therapy was undertaken at the ambulatory section of the Department of Neurology, Kralovske Vinohrady University Hospital in Prague.

  • Dynamic Neuromuscular Stabilization (DNS) MethodBehavioural

    Patients undergo ambulatory physiotherapy :1-hour duration, twice a week for one month and once a week for next two months (16 therapies in total).Therapy was undertaken at the Department of Rehabilitation and Sport Medicine, Motol University Hospital.

Study groups in NCT04973501
Study groupRoleWhat they receive
Manual physiotherapeutic correction (MFK) MethodExperimentalThe MFK was chosen for our clinical experience- it was developed in Czech Republic.The MFK Method consists of five established steps: anamnesis, assessment, diagnoses, treatment and checkup. In the course of all those steps, the computer MFK System software is used. This software allows us to display and visualize the patient´s functional muscle imbalance at the day of the assesment based on the assessment of muscle strength by manual muscle tests. Hereafter the physiotherapist performs muscle test and records results in the software. Then, the software visually describes the patient´s imbalance at the day of the assessment. Based on these diagnostic maps and the software suggestions the therapist chooses the body areas where the therapeutic techniques may be applied.
Receives: Behavioral: Manual physiotherapeutic correction (MFK) Method
Dynamic Neuromuscular Stabilization (DNS) MethodExperimentalDynamic Neuromuscular Stabilization (DNS) is a neurophysiological rehabilitative approach encompassing a set of functional tests assessing the quality of postural stabilization patterns and a treatment approach based on developmental kinesiology models. DNS diagnosis is based on comparison of the individual's postural stabilization pattern to the developmental stabilization pattern of healthy infants. The assessor uses DNS evaluation sheet to screen client's posture in 11 developmental positions if the patient can perform them all. If not, only the tests that the patient can perform sufficiently and safely serve for functional assessment. The strategy of DNS manual treatment is to utilize only those functional exercises in developmental positions that are the most suitable for the specific client. The goal is to improve spinal and joint stability by focusing on the global stabilization system consequently improving quality of movement and mobility.
Receives: Behavioral: Dynamic Neuromuscular Stabilization (DNS) Method

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Timed Up and Go (TUG)

    The TUG is a simple test used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.

    Measured: six months

  2. Berg Balance Scale (BBS)

    14 items objective measure of static balance and risk of falls (0 the best, 56 the worse)

    Measured: six months

  3. Dynamic Gait Index (DGI)

    The DGI tests the ability of the participant to maintain walking balance while responding to different task demands, through various dynamic conditions.

    It includes eight items, walking on level surfaces, changing speeds, head turns in horizontal and vertical directions, walking and turning 180 degrees to stop, stepping over and around obstacles, and stair ascent and descent.

    Each item is scored on a scale of 0 to 3, with 3 indicating normal performance and 0 representing severe impairment.

    The best possible score on the DGI is a 24

    Measured: six months

  4. Five times Sit to Stand test (5STS)

    The test assesses time when people stand and sit repeatedly five times. The lower the time to complete the test the better the outcome of the test.

    Measured: six months

  5. 2-Minute Walk Test (2MWT)

    The 2MWT is a simple measure of the distance a person can walk in two minutes. Rest breaks are allowed if needed. The person is encouraged to walk as fast as they can, safely, for two minutes. Walking aids can be used as needed e.g. for elderly people with a record made of walking aid used. If Assistive devices are used , they should be kept consistent and documented from test to test.

    Measured: six months

  6. Symbol Digit Modalities Test (SDMT)

    The SDMT involves a simple substitution task. Using a reference key, the examinee has 90 seconds to pair specific numbers with given geometric figures. Because examinees can give either written or spoken responses, the test is well suited for use with individuals who have motor disabilities or speech disorders.

    Measured: six months

  7. Four Square Step Test (FSST)

    The subject is required to sequentially step over four canes set-up in a cross configuration on the ground.

    At the start of the test, the subject stands in Square 1 facing Square 2. The aim is to step as fast as possible into each square with both feet in the following sequence: Square 2, 3, 4, 1, 4, 3, 2, 1 (clockwise to counterclockwise) Test procedure may be demonstrated, one practice trial is allowed prior to administering the test.

    Two trials are then performed, and the better time (in seconds) is taken as the score.

    Timing starts when the first foot contacts the floor in Square 2 and finishes when the last foot comes back to touch the floor in Square 1.

    Measured: six months

Secondary outcomes (6)
  1. Questionnaires - The Fatigue scale for motor and cognitive functions (FSMC)

    FSMC - is an assessment of MS-related cognitive and motor fatigue. A Likert-type 5-point scale (ranging from 'does not apply at all' to 'applies completely') produces a score between 1 and 5 for each scored question. Thus minimum value is 20 (no fatigue at all) and maximum value is 100 (severest grade of fatigue).

    Measured: six months

  2. Questionnaires -Multiple Sclerosis Impact Scale (MSIS-29)

    A 29-item self-report measure with 20 items associated with a physical scale and 9 items with a psychological scale. Items ask about the impact of MS on a day-to-day life in the past two weeks. All items have 5 response options: 1 "not at all" to 5" extremely". Each of the two scales is scored by summing the responses across items, then converting to a 0-100 scale where 100 indicates the greater impact of the disease on daily function (worse health).

    Measured: six months

  3. Questionnaires - Euroqol-5 dimensions-5 levels health questionnaire

    Descriptive system for health-related quality of life states in adults, consisting of five dimensions (Mobility, Self-care, Usual activities, Pain \& discomfort, Anxiety \& depression), each of which has three severity levels that are described by statements appropriate to that dimension. A higher number means a worse quality of life.

    Measured: six months

  4. Questionnaires -Multiple Sclerosis Walking Scale-12 (MSWS-12)

    The Multiple Sclerosis Walking Scale is a self-assessment scale which measures the impact of MS on walking. It consists of 12 questions concerning the limitations to walking due to MS during the past 2 weeks. Each item can be answered with 5 options, with 1 meaning no limitation and 5 extreme limitation.

    A total score can be generated and transformed to a 0 to 100 scale by subtracting the minimum score possible (12) from the patient's score, dividing by the maximum score possible minus the minimum possible (60-12 or 48), and multiplying the result by 100.

    Measured: six months

  5. Questionnaires - Rivermead Mobility (RMI)

    The Rivermead Mobility Index is a measuring instrument for functional loss related to body mobility. It measures the patient's ability to move her or his own body.

    14-self-reported items

    1 direct observation item Items progress in difficulty Items are coded as either 0 or 1, depending on whether the patient can complete the task according to specific instructions Items receive a score of 0 for a "No" response and 1 for a "Yes" response Total scores are determined by summing the points for all items A maximum of 15 points is possible; higher scores indicate better mobility performance A score of "0" indicates an inability to perform any of the activities on the measure

    Measured: six months

  6. Questionnaires- Activities-specific Balance Confidence Scale (ABC)

    The patient is asked to rate their confidence in their balance, while performing 16 activities, on a percentage scale of 0 to 100, where 0 is a certainty of falling or becoming unstable and 100 is complete confidence in the patient's own ability to stay balanced.

    The final score is the average of the 16 individual scores for each activity.

    Measured: six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jul 2021
  2. Study startMay 2016
  3. Primary completionMay 2018
  4. Study completionDec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The study was designed as parallel group (outpatients) randomized comparison of two kinds of physiotherapeutic interventions.
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04973501
Sponsor's protocol ID
EK-VP/25/0/2014/2
Status last verified
Jul 2021
First submitted
1 Jul 2021
Last updated
22 Jul 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Manual physiotherapeutic correction (MFK) Method and Dynamic Neuromuscular Stabilization (DNS) Method in people with Multiple Sclerosis and Rehabilitation, run by Charles University, Czech Republic.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Timed Up and Go (TUG) (time frame: six months). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in